Death’s legal definition must be responsive to advances in technology, and it must delineate between life and death. Knowing where to draw the line is difficult.
AMA J Ethics. 2020;22(12):E1055-1061. doi:
10.1001/amajethics.2020.1055.
A patient’s transition from “living” to “dying” is not socially marked in the same way death is marked, and this is both clinically and ethically relevant.
AMA J Ethics. 2020;22(12):E1062-1066. doi:
10.1001/amajethics.2020.1062.
Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Force feeding, unnecessary x-rays, misusing health information, and discharging unstable patients are classic dual-loyalty dilemmas reminiscent of the Holocaust.
AMA J Ethics. 2021;23(1):E38-45. doi:
10.1001/amajethics.2021.38.
Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.
Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.
AMA J Ethics. 2016;18(3):279-287. doi:
10.1001/journalofethics.2016.18.3.pfor4-1603.
Dr Adela Valdez joins Ethics Talk to discuss her article, coauthored with Lala Forrest, Alessandra Jimenez, and Dr Kim-Thu Pham: “How Should Medical Schools Foster Equity and Inclusion in Admissions?”
Dr Tonya Fancher joins Ethics Talk to discuss her article, coauthored with Dr Marjorie Westervelt, Dr Darius Billingsley, and Maya London: “Three Things Schools Should Do to Make Advancement Assessment Just”